SPY +0.71%
BND -0.38%
QQQ +1.58%
DIA -0.35%
VNQ -1.14%
GLD -0.72%
BTC +0.76%
AAPL +1.25%
GOOGL +0.68%
NVDA +3.09%
MSFT +1.62%
META -1.51%
AMZN +1.91%
TSLA +5.27%
UBER -1.89%
GS -1.40%
BAC -2.18%
JPM -0.69%
BRK.A +0.19%
COST -0.51%
XOM +1.83%
BABA -1.74%
WMT -2.36%
SPCX +6.62%
DIS -3.23%
F -1.46%
Live a richer life.
  • Discounts and special offers
  • Subscriber-only articles and interviews
  • Breaking news and trending topics

Already a subscriber?

By signing up, you accept Moneywise's Terms of Use, Subscription Agreement, and Privacy Policy.

Not interested ?

Home
Retirement
Worried senior couple checking their bills at home wavebreakmedia / Shutterstock

Senior Citizens League says Social Security COLA could be 3% in 2024 — but is a $53.50 bump really enough?

Bethan Moorcraft
Jul 25, 2023
Share
Email
Facebook
X
LinkedIn
Reddit
Follow us
Newsletter
Instagram
Facebook
Tiktok
X
Youtube

Follow us on Google for more Moneywise news

Add us on Google

New estimates are in for the Social Security cost of living adjustment (COLA) in 2024.

Using inflation data from June, The Senior Citizens League (TSCL) says the COLA could be 3% next year. This would increase the average monthly benefit for Social Security recipients by $53.50, from $1,787 to $1,840.

Don't miss

Must Read

When will the 2024 COLA be announced?

The official 2024 COLA will be announced in October and will be based on inflation data from July, August and September of this year.

Retire on your terms — we'll show you how.

By signing up, you accept Moneywise Terms of Use, Subscription Agreement, and Privacy Policy.

If inflation continues to slow like it did in June, the COLA could end up being lower than the estimated 3%.

Is 3% enough?

The impact of any increase to the COLA will depend on what happens to Medicare Part B premiums, which are expected to rise by around $10 per month or more in 2024, according to the 2023 Medicare Trustees Report.

Advertisement

Medicare premiums went down in 2023, giving seniors more breathing room — but that relief will be short-lived. The report estimates the average annual Part B premium will increase from $164.90 to $174.80 in 2024.

TSCL says insurance premiums could climb even higher due to “significant new costs”.

According to TSCL, Medicare’s coverage of a new Alzheimer’s drug could add another $5 onto the Part B premium for all recipients, potentially raising the 2024 premium to about $179.80 per month. The drug — Lecanemab — is expected to cost $26,000 per year for those without insurance.

If inflation continues to slow, the 2024 COLA could fall short of Medicare Part B premium increases, potentially leaving many who rely on Social Security benefits to make up the difference next year.

You May Also Like

Share this:
Bethan Moorcraft Reporter

Bethan Moorcraft is a reporter for Moneywise with experience in news editing and business reporting across international markets.

more from Bethan Moorcraft
Ray Cortez is fighting for his home after he says he was duped into signing over the deed 18 years ago.

Real Estate • Oct 03

'It's heartbreaking': 90-year-old faces eviction from Brooklyn home after he says he unknowingly fell for a deed scam 18 years ago. Here's what happened

Nancy and Paul Pelosi

News • Sep 26

Nancy Pelosi’s husband dumped thousands of Visa shares worth over $500K — just 2 months before the DOJ’s antitrust lawsuit. And it’s reigniting political trading rumors

Explore the latest

Disclaimer

The content provided on Moneywise is information to help users become financially literate. It is neither investment, tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities, enter into any loan, mortgage or insurance agreements or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter. Advertisers are not responsible for the content of this site, including any editorials or reviews that may appear on this site. For complete and current information on any advertiser product, please visit their website.

†Terms and Conditions apply.